Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:51:58 UTC |
---|
HMDB ID | HMDB0015372 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Clomipramine |
---|
Description | Clomipramine, the 3-chloro analog of imipramine, is a dibenzazepine-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, clomipramine does not affect mood or arousal, but may cause sedation. In depressed individuals, clomipramine exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Tertiary amine TCAs, such as clomipramine, are more potent inhibitors of serotonin reuptake than secondary amine TCAs, such as nortriptyline and desipramine. TCAs also down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine-H1 receptors, α1-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively. See toxicity section below for a complete listing of side effects. Clomipramine may be used to treat obsessive-compulsive disorder and disorders with an obsessive-compulsive component (e.g. depression, schizophrenia, Tourette's disorder). Unlabeled indications include panic disorder, chronic pain (e.g. central pain, idiopathic pain disorder, tension headache, diabetic peripheral neuropathy, neuropathic pain), cataplexy and associated narcolepsy, autistic disorder, trichotillomania, onchophagia, stuttering, premature ejaculation, and premenstrual syndrome. Clomipramine is rapidly absorbed from the gastrointestinal tract and demethylated in the liver to its primary active metabolite, desmethylclomipramine. |
---|
Structure | CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2 InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethyl-1-propanamine | ChEBI | 3-(3-CHLORO-5H-dibenzo[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine | ChEBI | 3-Chloroimipramine | ChEBI | Chlorimipramine | ChEBI | g 34586 | ChEBI | Monochlorimipramine | ChEBI | Anafranil | Kegg | Monohydrochloride, clomipramine | HMDB | Clomipramine maleate (1:1) | HMDB | Clomipramine monohydrochloride | HMDB | Hydiphen | HMDB | Hydrochloride, clomipramine | HMDB | Chlomipramine | HMDB | Clomipramine hydrochloride | HMDB |
|
---|
Chemical Formula | C19H23ClN2 |
---|
Average Molecular Weight | 314.852 |
---|
Monoisotopic Molecular Weight | 314.154976453 |
---|
IUPAC Name | (3-{14-chloro-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl}propyl)dimethylamine |
---|
Traditional Name | clomipramine |
---|
CAS Registry Number | 303-49-1 |
---|
SMILES | CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2 |
---|
InChI Identifier | InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3 |
---|
InChI Key | GDLIGKIOYRNHDA-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzazepines |
---|
Sub Class | Dibenzazepines |
---|
Direct Parent | Dibenzazepines |
---|
Alternative Parents | |
---|
Substituents | - Dibenzazepine
- Alkyldiarylamine
- Tertiary aliphatic/aromatic amine
- Azepine
- Benzenoid
- Aryl halide
- Aryl chloride
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Organopnictogen compound
- Amine
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 189.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.014 g/L | Not Available | LogP | 4.5 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M+H]+ | CBM | 174.3 | 30932474 |
|
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Clomipramine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9060000000-34352b7b1b6a78a55cd8 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clomipramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-066r-6391000000-e57dc447a97807ce527a | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine LC-ESI-QTOF , positive-QTOF | splash10-052r-9010000000-77a0afe2d49df71431d8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine LC-ESI-QFT , positive-QTOF | splash10-014i-2009000000-a1cc70dad4bb4c19ab7b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine LC-ESI-QFT , positive-QTOF | splash10-000i-9000000000-a9af3369f8d6da434fd0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine LC-ESI-QFT , positive-QTOF | splash10-052r-9000000000-3f1941447bc096ea9d73 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine LC-ESI-QFT , positive-QTOF | splash10-0a4r-9010000000-c6b5c5a56ac456cd8845 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine LC-ESI-QFT , positive-QTOF | splash10-0a4i-9010000000-8b5307526ea875a06881 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine LC-ESI-QFT , positive-QTOF | splash10-0a4i-9010000000-98746d4db184914ce871 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine LC-ESI-QFT , positive-QTOF | splash10-0a4i-9310000000-194486cca11709cd1b80 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine LC-ESI-QFT , positive-QTOF | splash10-0a4i-9600000000-da861dd5252aaff30e89 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine LC-ESI-QFT , positive-QTOF | splash10-0a4i-6900000000-efdead8e50e8b700d4bd | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine Linear Ion Trap , positive-QTOF | splash10-00di-0090000000-558a68c9d4919e7945a2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine Linear Ion Trap , positive-QTOF | splash10-00di-0090000000-489c71d87d96f5bafd40 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine Linear Ion Trap , positive-QTOF | splash10-014i-0009002000-3318f523b446a8d9d68e | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine Linear Ion Trap , positive-QTOF | splash10-014i-0009000000-8b8a1763c5358415b2b0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine 60V, Positive-QTOF | splash10-0a4r-9000000000-5c2c7aa10719beb2c160 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine 45V, Positive-QTOF | splash10-052r-9000000000-252b037815db33ff1554 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine 15V, Positive-QTOF | splash10-014i-4009000000-f6fbb8f3c1432560c648 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine 30V, Positive-QTOF | splash10-000i-9000000000-96e4294b38c6773a9dff | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine 10V, Positive-QTOF | splash10-014r-8009000000-47296607dea9797c1439 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine 35V, Positive-QTOF | splash10-05n0-9032000000-692d17611c53ffb0a6e9 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine 20V, Positive-QTOF | splash10-000i-9000000000-c3e3f7c405cca066b1a5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine 40V, Positive-QTOF | splash10-0a4r-9010000000-fa3cbee7da7ea050090c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine 60V, Positive-QTOF | splash10-0a4r-9010000000-88bad70b9055c4db776f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine 45V, Positive-QTOF | splash10-052r-9000000000-6204ac7352116dbd3864 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomipramine 75V, Positive-QTOF | splash10-0a4i-9010000000-2a09a2829877320e5044 | 2021-09-20 | HMDB team, MONA | View Spectrum |
|
---|